FDA Application
-
NDC Search Results on Active Ingredient: Diclofenac
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| DICLOFENAC SODIUM | 68788-9806-2 | Preferred Pharmaceuticals Inc. | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 68788-9806-3 | Preferred Pharmaceuticals Inc. | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 68788-9806-6 | Preferred Pharmaceuticals Inc. | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 68788-9806-8 | Preferred Pharmaceuticals Inc. | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 68788-9806-9 | Preferred Pharmaceuticals Inc. | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 69097-524-44 | Cipla USA Inc. | ANDA209903 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM; RANITIDINE HYDROCHLORIDE; CAPSAICIN | 69176-010-01 | TMIG, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| RANITIDINE HYDROCHLORIDE; PRILOCAINE; DICLOFENAC SODIUM; LIDOCAINE | 69176-010-03 | TMIG, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| LIDOCAINE; RANITIDINE HYDROCHLORIDE; PRILOCAINE; DICLOFENAC SODIUM | 69176-010-04 | TMIG, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 69238-2053-1 | Amneal Pharmaceuticals NY LLC | ANDA208077 | HUMAN OTC DRUG | ANDA |
| DICLOFENAC SODIUM | 69256-012-17 | Harris Teeter, LLC | ANDA208077 | HUMAN OTC DRUG | ANDA |
| DICLOFENAC SODIUM | 69256-012-35 | Harris Teeter, LLC | ANDA208077 | HUMAN OTC DRUG | ANDA |
| DICLOFENAC POTASSIUM | 69292-548-30 | Amici Pharmaceuticals LLC. | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC POTASSIUM | 69292-550-01 | Amici Pharmaceuticals LLC. | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC POTASSIUM | 69292-552-01 | Amici Pharmaceuticals LLC | ANDA215787 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC POTASSIUM | 69292-552-50 | Amici Pharmaceuticals LLC | ANDA215787 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC POTASSIUM | 69315-275-20 | Leading Pharma, LLC | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC POTASSIUM | 69315-506-09 | Leading Pharma, LLC | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| CAPSICUM OLEORESIN; DICLOFENAC SODIUM; RANITIDINE HYDROCHLORIDE | 69329-310-00 | Patchwerx Labs, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| CAPSICUM OLEORESIN; DICLOFENAC SODIUM | 69329-330-00 | Patchwerx Labs, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM; CAPSICUM OLEORESIN | 69329-335-00 | Patchwerx Labs, Inc. | ANDA074514 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM; CAPSICUM OLEORESIN | 69329-510-01 | Patchwerx Labs, Inc. | ANDA202027 | HUMAN PRESCRIPTION DRUG | ANDA |
| CAPSAICIN; DICLOFENAC SODIUM | 69336-202-01 | Sterling-Knight Pharmaceuticals, LLC | ANDA075185 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 69336-827-01 | Sterling-Knight Pharmaceuticals, LLC | ANDA208077 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 69621-300-01 | Shoreline Pharmaceuticals, Inc. | HUMAN PRESCRIPTION DRUG | unapproved drug other | |
| DICLOFENAC SODIUM | 69837-399-05 | International Brand Management, LLC | ANDA202027 | HUMAN PRESCRIPTION DRUG | ANDA |
| CAPSAICIN; DICLOFENAC SODIUM | 69837-500-05 | International Brand Management, LLC | ANDA202027 | HUMAN PRESCRIPTION DRUG | ANDA |
| DICLOFENAC SODIUM | 69842-729-01 | CVS Pharmacy | ANDA211253 | HUMAN OTC DRUG | ANDA |
| DICLOFENAC SODIUM | 69842-729-02 | CVS Pharmacy | ANDA211253 | HUMAN OTC DRUG | ANDA |
| DICLOFENAC SODIUM | 69842-729-03 | CVS Pharmacy | ANDA211253 | HUMAN OTC DRUG | ANDA |
-
